Cancer/Radiothérapie

Index des auteurs

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s):

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Quelle prise en charge pour un carcinome épidermoïde de stade T1 du canal anal ? Analyse des pratiques à partir des patients inclus dans la cohorte Anabase

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): M. Bacci, L. Quéro, E. Barbier, L. Parrot, P. Pommier, L.-A. Bazire, C. Lepage, L. Abramowitz, Groupe en recherche de proctologie (Grep) de la Société nationale française de coloproctologie (SNFCP), V. Vendrely

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Modélisation préclinique de la cystite radique chronique et étude du potentiel d’une thérapie cellulaire

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): C. Brossard, A.-C. Lefranc, M. Dos Santos, M. Benadjaoud, C. Demarquay, V. Buard, G. Tarlet, C. Squiban, C. Linard, N. Mathieu, R. Granger, A. Sache, D. Denais Laliève, J.-M. Simon, M. Benderitter, F. Milliat, A. Chapel

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Cloisonnement du cul-de-sac de Douglas par suture péritonéale laparoscopique : une approche innovante pour prévenir le risque de grêle radique lors de la radiothérapie curative des tumeurs urologiques

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): M. Loo, C. Martinez Gomez, J. Khalifa, C. Chira, L. Piram, G. Ferron, P. Graff

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Risque d’implantation de stimulateur cardiaque après traitement pour un cancer du sein : étude à partir des données médicoadministratives de l’Assurance maladie

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): S. Jacob, Y. Errahmani, M.-O. Bernier, Q. Voglimacci, J. Thariat, M. Lapeyre-Mestre, J. Ferrières, S. Boveda

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Marges de sécurité pour la délinéation de l’artère interventriculaire antérieure pour la radiothérapie du cancer du sein

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): É.M. Nicolas, Y. Kirova, C. Laporte, N. Khalfallah

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Essai clinique évaluant l’efficacité des injections de cellules stromales mésenchymateuses pour le traitement des complications pelviennes chroniques induites par la radiothérapie

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): A. Chapel, A. Sémont, C. Linard, N. Mathieu, C. Demarquay, C. Squiban, F. Milliat, M. Benderitter, H. Rouard, C. Martinaud, J.-J. Lataillade, N.-C. Gorin, M. Mohty, J.-M. Simon

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Association du double blocage de HER2 et de la radiothérapie pour les cancers du sein exprimant HER2

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): S. Ben Dhia, P. Loap, D. Loriat, A. Vincent Salomon, K. Cao, L. Escalup, A. Fourquet, Y. Kirova

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Radiothérapie avec contrôle par IRM des cancers de la prostate

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): N. Salem, P. Fau, H. Mailleux, A. Tallet, P. Eustache

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Évaluation de la qualité d’imagerie d’une IRM à bas champ couplé à un accélérateur linéaire

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): P. Debuire, S. Valdenaire, N. Ailleres, J. Prunaretty, S. Simeon, O. Riou, D. Azria, P. Fenoglietto

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Réirradiation de récidives intraprostatiques isolées guidée par IRM : retour d’expérience clinique à l’Institut du cancer de Montpellier (ICM)

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): M. Michalet, P. Fenoglietto, S. Valdenaire, P. Debuire, M. Charissoux, C. Llacer-Moscardo, D. Azria, O. Riou

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Retour d’expérience clinique à propos des 200 premiers patients pris en charge par radiothérapie guidée par l’IRM à l’institut Paoli-Calmettes

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): M. Tyran, P. Fau, H. Mailleux, P. Eustache, M. Benkreira, N. Salem, V. Favrel, L. Gonzague, L. Moureau, L. Varela, P. Annede, A. Tallet

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Radiothérapie en conditions stéréotaxiques de métastases rachidiennes non compressives par technique de dynamic wave arc sur un accélérateur linéaire dédié Vero (Brainlab®)

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): B. Pichon, D. Marre, B. Pinel, C. Chevelle, E. Caillot, P. Dudouet, O. Gallocher, G. Jimenez, F. Thouveny, D. Zarate, J. Mazurizer, I. Latorzeff

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Impact dosimétrique et clinique de la pose d’un espaceur rectal dans le traitement de cancer de prostate localisé par irradiation en conditions stéréotaxiques

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): M. Ung, A. Bossi, L. Abbassi, J. Vautier, M. Chevé, V. Anthonipillai, P. Blanchard

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Impact éducatif sur les internes en oncologie radiothérapie de la délinéation automatique des patients atteints d’un cancer de la tête et du cou

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): T. Sarrade, M. Gautier, A. Schernberg, C. Jenny, A. Orthuon, P. Maingon, F. Huguet

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Robustesse du guidage surfacique en comparaison avec le spiromètre dans la mise en place du blocage respiratoire pour le traitement du cancer du sein

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): C. Messina, A.-L. Guibert, G. Martin, V. Chauvet, N. Bonichon-Lamichhane, C. Debelleix, P. Régnault de la Mothe, J.P. Taupiac, H. Mineur

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Analyse radiomique de la distribution dosimétrique tridimensionnelle pour la prédiction de la toxicité liée à la radiothérapie du cancer du col de l’utérus

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): F. Lucia, V. Bourbonne, D. Visvikis, O. Miranda, G. Dissaux, O. Pradier, F. Tixier, V. Jaouen, J. Bert, M. Hatt, U. Schick

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Analyse radiomique de la distribution dosimétrique tridimensionnelle pour la prédiction de la toxicité liée à la radiothérapie du cancer pulmonaire

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): V. Bourbonne, R. Da-Ano, F. Lucia, G. Dissaux, J. Bert, O. Pradier, D. Visvikis, M. Hatt, U. Schick

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Apport d’algorithmes de délination et de planification basés sur l’intelligence artificielle pour la radiothérapie du cancer de la prostate

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): J. Mazurier, G. Sidorski, B. Pichon, B. Pinel, G. Jimenez, O. Gallocher, J. Camilleri, N. Mathy, D. Marre, D. Zarate, Y. Marty, V. Connord, I. Latorzeff

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Outils <em>open data</em> d’extraction, de normalisation et d’exploitation de données cliniques de toxicité et de données de dosimétrie : preuve de concept à partir de données de soins courants

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): A. Jou, S. Guihard, J.M. Fontbonne, J.B. Clavier, C. Fontbonne, C. Mazzara, R. Eugène, M. Piot, L. Jung, J. Thariat

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Comparaison intercentre de la toxicité aiguë de 2052 patientes après radiothérapie mammaire normo- ou hypofractionnée à partir d’une fiche standardisée d’évaluation

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): I. Issoufaly, S. Rivera, S. Guihard, J.B. Clavier, E. Rémi, C. Vigneron, I. Menoux, C. Mazzara, S. Servagi Vernat, S. Bellefquih, C. Petit

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Analyse médicoéconomique de la radiothérapie stéréotaxique robotisée prostatique par comparaison à la prostatectomie totale robot-assistée en France

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): L. Farah, N. Scher, M. Zerbib, N. Martelli, I. Borget, T. Guetta, O. Bauduceau, A. Tolédano

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Bénéfices dosimétriques de l’adaptation pour la radiothérapie stéréotaxique guidée par IRM pour les cancers du pancréas localement évolués

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): M. Michalet, P. Fenoglietto, S. Valdenaire, P. Debuire, M. Grapin, S. Demontoy, C. Maurin, D. Azria, O. Riou

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Étude dosimétrique des patients pris en charge pour un adénocarcinome rectal dans l’essai Accord 12/0405-Prodige 02 ayant été atteints d’une rechute locale

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): N. Meillan, A. Orthuon, P. Chauchat, J.-P. Gérard, F. Huguet

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Acceptance mécanique et dosimétrique d’un dispositif de radiothérapie guidé par IRM

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): S. Valdenaire, P. Debuire, N. Aillères, A. Morel, D. Trauchessec, O. Riou, D. Azria, P. Fenoglietto

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Évaluation des corrections 6D de positionnement entre et pendant les fractions en radiothérapie stéréotaxique des métastases osseuses : influence du temps de traitement

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): A. Hadj Henni, L. Lebret, F. Guérault, M. Daras, E. Dellière, G. Bulot, C. Lesueur, S. Thureau, D. Gensanne

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Radiothérapie postopératoire des cancers ORL : recommandations de délinéation des lambeaux

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): J. Le Guevelou, V. Bastit, P.Y. Marcy, L. Guzène, M. Gérard, A. Larnaudie, A. Coutte, A. Beddok, A. Calugaru, A. Johnson, B. Géry, A. Lasne-Cardon, J. Thariat

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Validation interne au GORTEC du consensus international de délinéation des CTV-P pour les cancers des VADS (méthode de consensus formalisé) : résultats des phases de cotation

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): M. Lapeyre, Y. Pointreau, J. Biau, P. Boisselier, P. Blanchard, P. Graff-Cailleaud, F. Huguet, S. Racadot, M. Alfonsi, J. Castelli, L. Martin, X.S. Sun, C. Sire, Y. Tao, J. Bourhis, J. Thariat

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Intelligence artificielle interprétable pour la prédiction de la survie dans le cancer de prostate

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): J.-E. Bibault, L. Xing

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Capture, restitution et exploitation multicentrique des données de vie réelle en radiothérapie

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): J.B. Clavier, L. Jung, R. Eugène, C. Mazzara, S. Servagi, S. Rivera, I. Issoufaly, S. Bellefqih, J.-M. Hannoun-Lévi, C. Petit, J. Feuillade, J.-M. Fontbonne, N. Bonnet, A. Jou, M. Piot, X. Liem, J. Thariat, S. Guihard

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Comparaison de l’exposition des sous-structures cardiaques lors de l’irradiation mammaire locorégionale par protons et par arcthérapie volumétrique modulée, avec ou sans blocage inspiratoire

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): P. Loap, F. Goudjil, B. Baron, M. Ribeiro, A. Fourquet, Y. Kirova

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Étude des mouvements pendant les fractions de patientes traitées par irradiation adjuvante pour un cancer du sein grâce au système de positionnement Catalyst

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): S. Lals, F. Crop, A.M. Bimbai, X. Mirabel, D. Pasquier

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Impact de la sarcopénie sur la survie globale et la survie sans progression après radiothérapie ou chimioradiothérapie pour le carcinome épidermoïde de la tête et du cou

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): S. Thureau, L. Lebret, J. Lequesne, S. Mihailescu, R. Mallet, M. Cabourg, L. Lefebvre, S. Dandoy, R. Modzelewski, F. Clatot

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Apport de la radiomique sur IRM pour prédire la réponse à 2 ans après chimioradiothérapie des cancers du canal anal localement évolués

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): N. Giraud, T. Aparicio, P. Ronchin, L.-A. Bazire, K. Le Malicot, C. Lemanski, X. Mirabel, P.-L. Étienne, A. Lièvre, W. Cacheux, A. Darut-Jouve, C. de la Fouchardière, G. Breysacher, D. Argo-Leignel, A. Tessier, N. Magné, M. Ben Abdelghani, C. Lepage, O. Saut, V. Vendrely

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Mise en place des traitements stéréotaxiques adaptatifs sur accélérateur linéaire couplé à l’IRM au sein d’un département de radiothérapie

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): M. Rouffiac Thouant, M. Quivrin, C. Chevalier, P.A. Laurent, E. Martin, J. Boustani, A. Petitfils, I. Bessières, L. Aubignac, G. Truc, K. Peignaux Casasnovas, G. Créhange

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Impact de l’épidémie à coronavirus 2019 sur l’organisation d’un service de radiothérapie : expérience du télétravail pour les manipulateurs

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): A.J. Le Jeanne, C. Bouvet

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Dépistage systématique de l’épidémie à coronavirus 2019 en radiothérapie par scanographie thoracique et PCR : expérience d’un centre

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): R. Sun, S. Ammari, S. Achkar, S. Bockel, N. Douir, G. Mevel, K. Diop, S. Corbin, F. Hubert, G. Brusadin, M. Merad, K. Ka, A. Bossi, S. Rivera, C. Chargari, É. Deutsch

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Radiothérapie ablative des tachycardies ventriculaires : impact des mouvements cardiaques et respiratoires sur la définition du volume cible

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): J. Bellec, A. Simon, N. Jaksic, P. Caille, M. Léderlin, C. Lafond, R. Martins, R. de Crevoisier

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Prise en charge d’une tachycardie ventriculaire par radiothérapie en conditions stéréotaxiques : première expérience

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): M. Doré, S. Josset, E. Mervoyer, J.-B. Gourraud, M. Bonnin, P. Cadot, S. Chiavassa, G. Kerdanet, J. Lebreton, H. Lorand, T. Marsac, M. Raimond, S. Rousset, J.-M. Serfaty, G. Delpon, S. Supiot

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Remove ads

Impact pronostique d’un « sous-dosage » des zones avides de fluorodésoxyglucose sur la tomographie par émission de positrons préthérapeutique pour les patientes prises en charge par chimioradiothérapie et curiethérapie pour un cancer du col de l’utérus

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): F. Lucia, V. Bourbonne, G. Dissaux, O. Miranda, M. Mauguen, O. Pradier, R. Abgral, U. Schick

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Faisabilité dosimétrique d’une radiothérapie stéréotaxique cérébrale basée sur l’IRM, à l’aide de scanographies synthétiques générées par réseau adversatif génératif

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): V. Bourbonne, V. Jaouen, C. Hognon, N. Boussion, F. Lucia, O. Pradier, J. Bert, D. Visvikis, U. Schick

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Étude prospective « BioPro-RCMI » sur l’utilisation du ballonnet Bioprotect® comme espaceur rectal pour la radiothérapie avec modulation d’intensité de l’adénocarcinome prostatique de risque intermédiaire

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s): I. Latorzeff, E. Bogart, D. Marre, M.C. Le Deley, É. Lartigau, D. Pasquier

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Issue Contents

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s):

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Editorial Board

Publication date: October 2020Source: Cancer/Radiothérapie, Volume 24, Issues 6–7Author(s):

Cancer/Radiothérapie

Sun Sep 20, 2020 22:54

Mark above section as read

 Clinical and Translational Science

Priority Review Vouchers: GAO Report Provides Scant Evidence of Success

Clinical and Translational Science

Sat Sep 19, 2020 20:43

Expression of Paracrine Effectors in Human Adipose‐Derived Mesenchymal Stem Cells Treated With Plasma From Brown Bears (Ursus arctos)

Adipose‐derived mesenchymal stem cells (ADSCs) are promising candidates for novel cell therapeutic applications. Hibernating brown bears sustain tissue integrity and function via unknown mechanisms, which might be plasma borne. We hypothesized that plasma from hibernating bears may increase the expression of favorable factors from human ADSCs. In an experimental study, ADSCs from patients with ischemic heart disease were treated with interventional media containing plasma from hibernating and active...

Clinical and Translational Science

Sat Sep 19, 2020 12:41

Mark above section as read

 European Journal of Cancer

Letter to the European Dermatology Forum, the European Association of Dermato-Oncology and the European Organization for Research and Treatment of Cancer on guidelines on basal cell carcinoma

Publication date: Available online 19 September 2020Source: European Journal of CancerAuthor(s): Alessandro A.E. Testori, Christian Kunte, James A.P. Clover, Falk G. Bechara, Giulia Bertino

European Journal of Cancer

Sun Sep 20, 2020 13:07

Malignant peritoneal cytology: Areas of unmet need for evidence

Publication date: Available online 19 September 2020Source: European Journal of CancerAuthor(s): Koji Matsuo, Jason D. Wright, Shinya Matsuzaki, Lynda D. Roman, Philipp Harter, Maximilian Klar

European Journal of Cancer

Sun Sep 20, 2020 13:07

Letter to the Editor: considerations about recent findings on long-term adverse events of PD-1/PD-L1 checkpoint inhibitors

Publication date: November 2020Source: European Journal of Cancer, Volume 139Author(s): Olga Nigro, Alessio Cortellini

European Journal of Cancer

Sat Sep 19, 2020 18:01

Phase I trials and therapeutic intent in the age of precision oncology: What is a patient's chance of response?

Publication date: November 2020Source: European Journal of Cancer, Volume 139Author(s): Derrick L. Tao, Thomas Kartika, Audrey Tran, Vinay Prasad

European Journal of Cancer

Sat Sep 19, 2020 18:01

Tobacco-related cancers in Europe: The scale of the epidemic in 2018

Publication date: November 2020Source: European Journal of Cancer, Volume 139Author(s): Ivana Kulhánová, David Forman, Jerome Vignat, Carolina Espina, Hermann Brenner, Hans H. Storm, Linda Bauld, Isabelle Soerjomataram

European Journal of Cancer

Sat Sep 19, 2020 18:01

Repeated complete response with long-term control of BRAF-mutant melanoma by multiple rechallenges with dabrafenib plus trametinib

Publication date: November 2020Source: European Journal of Cancer, Volume 139Author(s): Katsuhito Sasaki, Yasuhiro Nakamura, Natsuki Baba, Yukiko Teramoto, Akifumi Yamamoto

European Journal of Cancer

Sat Sep 19, 2020 18:01

Biosimilars in oncology: Effects on economy and therapeutic innovations

Publication date: November 2020Source: European Journal of Cancer, Volume 139Author(s): Kai Hübel, Florian Kron, Michael Patrick Lux

European Journal of Cancer

Fri Sep 18, 2020 23:50

Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 – Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas

Publication date: Available online 17 September 2020Source: European Journal of CancerAuthor(s): Linda Marklund, Stefan Holzhauser, Caroline de Flon, Mark Zupancic, David Landin, Aeneas Kolev, Linnea Haeggblom, Eva Munck-Wikland, Lalle Hammarstedt-Nordenvall, Tina Dalianis, Anders Näsman

European Journal of Cancer

Fri Sep 18, 2020 23:50

Mark above section as read

 European Journal of Surgical Oncology (EJSO)

Socioeconomic status significantly contributes to the likelihood of immediate postmastectomy breast reconstruction in the Netherlands: A nationwide study

Publication date: Available online 19 September 2020Source: European Journal of Surgical OncologyAuthor(s): M.D. Filipe, S. Siesling, M.R. Vriens, P.J. van Diest, A.J. Witkamp, M.A.M. Mureau

European Journal of Surgical Oncology (EJSO)

Sun Sep 20, 2020 20:19

Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin

Publication date: Available online 19 September 2020Source: European Journal of Surgical OncologyAuthor(s): Robert A. Nagourney, Steven Evans, Peter H. Tran, Adam J. Nagourney, Paul H. Sugarbaker

European Journal of Surgical Oncology (EJSO)

Sun Sep 20, 2020 20:19

Comments on “Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy”

Publication date: Available online 19 September 2020Source: European Journal of Surgical OncologyAuthor(s): Loek A.W. de Jong, Nielka P. van Erp, Philip R. de Reuver

European Journal of Surgical Oncology (EJSO)

Sun Sep 20, 2020 20:19

Reply to: Comments on “Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy”

Publication date: Available online 19 September 2020Source: European Journal of Surgical OncologyAuthor(s): W.J. Koemans, J.W. van Sandick, A.D.R. Huitema

European Journal of Surgical Oncology (EJSO)

Sun Sep 20, 2020 20:19

Primary site disease and recurrence location in ovarian cancer patients undergoing primary debulking surgery vs. interval debulking surgery

Publication date: Available online 19 September 2020Source: European Journal of Surgical OncologyAuthor(s): Capozzi Vito Andrea, Uccella Stefano, Sozzi Giulio, Ceccaroni Marcello, Mautone Daniele, Armano Giulia, Franchi Massimo, Chiantera Vito, Berretta Roberto

European Journal of Surgical Oncology (EJSO)

Sat Sep 19, 2020 19:13

Remove ads

Impact of neoadjuvant chemotherapy on the postoperative pathology of locally advanced cervical squamous cell carcinomas: 1:1 propensity score matching analysis

Publication date: Available online 18 September 2020Source: European Journal of Surgical OncologyAuthor(s): Pengfei Li, Ziyu Fang, Weili Li, Min Hao, Wuliang Wang, Shan Kang, Jianxin Guo, Ying Yang, Yan Ni, Weidong Zhao, Anwei Lu, Bin Ling, Donglin Li, Jinghe Lang, Chunlin Chen, Ping Liu

European Journal of Surgical Oncology (EJSO)

Sat Sep 19, 2020 19:13

Aggressive recurrences determine oncologic outcomes after resection of liver metastases from primary right colon cancer: Results of a case-control study

Publication date: Available online 17 September 2020Source: European Journal of Surgical OncologyAuthor(s): Giuseppe Zimmitti, Elena Panettieri, Francesco Ardito, Caterina Mele, Vellone Maria, Edoardo Rosso, Gennaro Nuzzo, Felice Giuliante

European Journal of Surgical Oncology (EJSO)

Fri Sep 18, 2020 22:21

Mark above section as read

 Genes, Chromosomes and Cancer

Additional comments regarding IGH studies in multiple myeloma

Genes, Chromosomes and Cancer

Sat Sep 19, 2020 15:44

Mark above section as read

 International Journal of Cancer

Predictors of Mammographic Microcalcifications

ABSTRACT We examined the association between established risk factors for breast cancer and microcalcification clusters and their asymmetry. A cohort study of 53,273 Swedish women aged 30‐80 years, with comprehensive information on breast cancer risk factors and mammograms, was conducted. Total number of microcalcification clusters and the average mammographic density area were measured using a Computer Aided Detection system and the STRATUS method, respectively. A polygenic risk score for breast...

International Journal of Cancer

Sat Sep 19, 2020 15:23

Integrating Proteomics into Precision Oncology

ABSTRACT DNA and RNA sequencing are increasingly applied in precision oncology, where molecular tumor boards evaluate the actionability of genetic events in individual tumors to guide targeted treatment. To work towards an additional level of patient characterization, we assessed the abundance and activity of 27 proteins in 134 patients whose tumors had previously undergone whole‐exome and RNA sequencing within the MASTER program of NCT Heidelberg. Proteomic and phospho‐proteomic targets were selected...

International Journal of Cancer

Sat Sep 19, 2020 15:22

A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy (RELAIS) translational biomarker phase II pilot study

Abstract The predictive effect of circulating tumor DNA (ctDNA) in colorectal cancer (CRC) treatment is still highly discussed. The primary objective of this study was to investigate a possible prognostic/predictive value of ctDNA under regorafenib treatment. This prospective multicenter translational biomarker phase II pilot study enrolled 30 metastatic CRC patients (67% men, 33% women) treated with regorafenib. ctDNA was assessed in plasma before treatment start and at defined time points during...

International Journal of Cancer

Sat Sep 19, 2020 15:22

Small but Strong: Mutational and functional landscapes of micronuclei in cancer genomes

Abstract Micronuclei, small spatially‐separated, nucleus‐like structures, are a common feature of human cancer cells. There are considerable heterogeneities in the sources, structures and genetic activities of micronuclei. Accumulating evidence suggests that micronucleus and main nucleus represent separate entities with respect to DNA replication, DNA damage sensing and repairing capacity because micronuclei are not monitored by the same checkpoints nor covered by the same nuclear envelope as the...

International Journal of Cancer

Sat Sep 19, 2020 15:22

Mark above section as read

 Radiotherapy and Oncology

Estimating acute urinary retention risk post prostate high dose-rate (HDR) brachytherapy: A clinical-based recursive partitioning analysis

The use of high-dose rate (HDR) brachytherapy in the treatment of prostate cancer is now well established. According to American Society of Clinical Oncology/Cancer Care Ontario brachytherapy guidelines [1], HDR- or Low Dose-Rate brachytherapy should be offered as a boost to external beam radiotherapy (EBRT) in eligible intermediate and high-risk patients and may be an option as monotherapy in patients with more favourable disease.

Radiotherapy and Oncology

Sun Sep 20, 2020 03:00

Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials

Preoperative radiotherapy followed by a total mesorectal excision (TME) is the standard of care for locally advanced rectal cancer (LARC)[1,2].

Radiotherapy and Oncology

Sun Sep 20, 2020 03:00

Rate of radiation-induced microbleed formation on 7T MRI relates to cognitive impairment in young patients treated with radiation therapy for a brain tumor

Brain tumors are the most common solid cancer in children younger than 15 years old.[1] Radiation therapy (RT) remains integral to the treatment of pediatric brain tumors, having significantly improved disease prognosis for common malignant tumors such as medulloblastomas: in average-risk disease, the 5-year survival for these tumors is now at 70-80%.[2,3] Elevated 5-year survival rates have also been achieved through the use of RT as a stand-alone therapy in the treatment of germinomas.[4] Despite...

Radiotherapy and Oncology

Sat Sep 19, 2020 03:00

Letter to the editor concerning offersen et al., [Radiother oncol 2015; 114: 3-10]

With great interest we read ‘ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer’ by Offersen et al [1]. We wish to congratulate the authors on their excellent work describing easily applicable, comprehensive delineation guidelines.

Radiotherapy and Oncology

Sat Sep 19, 2020 03:00

Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer

One out of thirty cancer patients worldwide is diagnosed with cervical cancer [1] and the 5-year overall survival rate for the early stage group is 91% [2]. Half of all diagnosed cervical cancer patients is younger than 35 years [3], whereby late radiation-induced toxicities have a large influence on quality of life [4]. Thus, prevention of late radiation-induced side effects becomes increasingly relevant.

Radiotherapy and Oncology

Fri Sep 18, 2020 03:00

Mark above section as read

 Strahlentherapie und Onkologie

Implementing a new scale for failure mode and effects analysis (FMEA) for risk analysis in a radiation oncology department

Abstract Purpose Patients and staffs are endangered by different failure modes during clinical routine in radiation oncology and risks are difficult to stratify. We implemented the method of failure mode and effects analysis (FMEA) via questionnaires in our institution and introduced an adapted scale applicable for radiation oncology. Methods Failure...

Strahlentherapie und Onkologie

Sat Sep 19, 2020 03:00

Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma

Abstract Purpose Mediastinal radiotherapy (RT), especially when combined with bleomycin, may result in substantial pulmonary morbidity and mortality. The use of modern RT techniques like intensity-modulated radiotherapy (IMRT) is gaining interest to spare organs at risk. Methods We evaluated 27 patients who underwent RT for Hodgkin’s lymphoma between...

Strahlentherapie und Onkologie

Fri Sep 18, 2020 03:00

#Stayathome: Smart working for radiation oncologists during the corona pandemic

Strahlentherapie und Onkologie

Fri Sep 18, 2020 03:00

Mark above section as read